Moderna Covid-19 Vaccine
US pharmaceutical giant Moderna on Monday reported a "robust neutralizing antibody response" to its Covid vaccine in children aged 6-11, and said that it will submit the trial data to global regulators soon.
Sweden's Public Health Agency on Wednesday recommended a temporary halt to the use of the Moderna Covid-19 vaccine among young adults, citing concerns over rare side effects to the heart.
16 Mar 2021
US manufacturer Moderna on Tuesday said it has started Covid-19 vaccine trials for children aged from 6 months to under 12 years old, with plans to enroll about 6,750 participants.
13 Feb 2021
US biotech firm Moderna said Friday it was seeking clearance with regulators around the world to put 50 percent more coronavirus vaccine into each of its vials as a way to quickly boost current supply levels.
8 Jan 2021
Britain on Friday approved a third Covid vaccine for its mass inoculation drive, as regulators gave the green light to a jab developed by US firm Moderna.